GO
Loading...

Allergan Inc

More

  • UPDATE 1-Allergan-bidder Valeant cuts 2014 outlook Thursday, 31 Jul 2014 | 7:54 AM ET

    July 31- Canada's Valeant Pharmaceuticals International Inc, embroiled in a bitter battle to take over Botox-maker Allergan Inc, cut its full-year profit and revenue forecasts to reflect the sale of its rights to several skincare products.

  • Final Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 6:02 PM ET

    Allergan rose $1.27 or. 7 percent, to $172.17. Baxter International Inc. fell$. 25 or. 3 percent, to $76.09. Boston Scientific Corp. rose$. 25 or 1.9 percent, to $13.14.

  • Midday Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 1:22 PM ET

    Allergan rose $1.25 or. 7 percent, to $172.15. Baxter International Inc. rose$. 07 or. 1 percent, to $76.41. Boston Scientific Corp. rose$. 18 or 1.4 percent, to $13.07.

  • Early Glance: Medical Devices companies Wednesday, 30 Jul 2014 | 10:42 AM ET

    Allergan rose $1.15 or. 7 percent, to $172.05. Baxter International Inc. rose$. 54 or. 7 percent, to $76.88. Boston Scientific Corp. rose$. 02 or. 2 percent, to $12.91.

  • Final Glance: Medical Devices companies Monday, 28 Jul 2014 | 6:04 PM ET

    Allergan rose$. 09 or. 1 percent, to $170.15. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97. Medtronic fell$. 14 or. 2 percent, to $62.76.

  • Midday Glance: Medical Devices companies Monday, 28 Jul 2014 | 1:31 PM ET

    Allergan fell$. 02 or percent, to $170.04. Baxter International Inc. fell$. 28 or. 4 percent, to $76.38. Boston Scientific Corp. fell$. 20 or 1.5 percent, to $12.91.

  • Early Glance: Medical Devices companies Monday, 28 Jul 2014 | 10:33 AM ET

    Allergan rose$. 55 or. 3 percent, to $170.61. Baxter International Inc. fell$. 10 or. 1 percent, to $76.55. Boston Scientific Corp. fell$. 14 or 1.1 percent, to $12.97.

  • July 25- Allergan Inc, known best for its Botox wrinkle treatment, said on Friday that European Union regulators had recommended use of its eye drug Ozurdex be extended to treat patients with diabetic macular edema.

  • Final Glance: Medical Devices companies Thursday, 24 Jul 2014 | 6:22 PM ET

    Allergan fell $1.86 or 1.1 percent, to $170.57. Baxter International Inc. rose$. 16 or. 2 percent, to $77.00. Boston Scientific Corp. rose$. 24 or 1.8 percent, to $13.26.

  • Midday Glance: Medical Devices companies Thursday, 24 Jul 2014 | 1:23 PM ET

    Allergan fell$. 78 or. 5 percent, to $171.65. Baxter International Inc. rose$. 20 or. 3 percent, to $77.04. Boston Scientific Corp. rose$. 09 or. 7 percent, to $13.11.

  • Early Glance: Medical Devices companies Thursday, 24 Jul 2014 | 11:37 AM ET

    Allergan fell $1.51 or. 9 percent, to $170.92. Baxter International Inc. fell$. 13 or. 2 percent, to $76.71. Boston Scientific Corp. rose$. 02 or. 2 percent, to $13.04.

  • Republican lawmaker to grill U.S. SEC over Ackman tactics Thursday, 24 Jul 2014 | 12:01 AM ET

    WASHINGTON, July 24- A U.S. lawmaker will pressure the U.S. Securities and Exchange Commission on Thursday to consider a raft of reforms, after William Ackman's aggressive efforts to take over Allergan Inc raised concerns about loose rules governing disclosure and shareholder voting.

  • Final Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 6:02 PM ET

    Allergan fell$. 71 or. 4 percent, to $170.43. Boston Scientific Corp. rose$. 30 or 2.4 percent, to $12.85. Medtronic rose$. 30 or. 5 percent, to $62.71.

  • Early Glance: Medical Devices companies Tuesday, 22 Jul 2014 | 11:16 AM ET

    Allergan rose $1.04 or. 6 percent, to $172.18. Baxter International Inc. rose$. 55 or. 7 percent, to $76.66. Boston Scientific Corp. rose$. 23 or 1.8 percent, to $12.78.

  • Business Highlights Monday, 21 Jul 2014 | 6:01 PM ET

    Microsoft makes design central to its future. Before Ralf Groene helped devise the look and feel of Microsoft's Surface tablet, he designed food— or "food concepts," he says, such as dried noodles that come wrapped around a pair of chopsticks and a fork that squeezes out sauce.

  • Stocks end lower amid caution on Ukraine and Gaza Monday, 21 Jul 2014 | 4:21 PM ET
    Trader on the floor of the New York Stock Exchange.

    Stocks declined Monday as global disapproval of Russia increased after the downing of a passenger plane in Ukraine.

  • Ackman says Valeant-Allergan deal looks closer-CNBC Monday, 21 Jul 2014 | 1:11 PM ET

    July 21- Investor William Ackman, who owns nearly 10 percent of Botox maker Allergan Inc, said on Monday that the likelihood of Valeant Pharmaceuticals International Inc succeeding in its hostile takeover for Allergan increased on Monday.

  • Ackman: Will not raise offer for Allergan     Monday, 21 Jul 2014 | 12:31 PM ET

    Bill Ackman, Pershing Square, explains why he is not upping his bid for Allergan. The market clearly thinks the chance of Valeant buying Allergan has gone up, says Ackman.

  • Big pharma battle escalates     Monday, 21 Jul 2014 | 12:30 PM ET

    CNBC's Meg Tirrell reports Allergan posted Q2 results that beat on earnings and sales, as the company announced its restructuring plans, which may include an acquisition of its own.

  • Midday movers: Allergan, BB&T, McDonald's & More Monday, 21 Jul 2014 | 12:24 PM ET
    Trader on the floor of the New York Stock Exchange.

    Some of Monday's midday movers: